FLUDEOXYGLUCOSE F18

Post-LOE

fludeoxyglucose f-18

Precision BioSciences
ANDAINTRAVENOUSINJECTABLE
Approved
Apr 2015
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

Radiopharmaceutical Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Company
Precision BioSciences
Precision BioSciences
DURHAM, NC
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers